Increased IL-2 expression shifts the immune response toward tumor attack, allowing NK cells, CD8+ T cells, and CD4+ T cells to infiltrate the tumor microenvironment, while miR-217 downregulates mtKRAS expression. This evidence concerns the gene CD4 and neoplasm.